Exploring the impact of a celebrity health announcement on public awareness
the ONA take:
Breast cancer treatment options received considerable media attention when Angelina Jolie revealed she had undergone prophylactic double mastectomy for BRCA1 positivity.
In this first study of media-related impact on public awareness, these authors surveyed two female population-matched cohorts of 1,000 participants each, ages 18 to 65 years, in two polls. Poll 1 was taken in March 2013, before Ms. Jolie’s announcement in May 2013; poll 2 was taken in June 2013, after the announcement.
The authors report a significant increase in awareness of reconstructive breast surgery after breast cancer-related mastectomy. In particular, awareness of autologous tissue and single-stage reconstructions was higher in poll 2, with approximately 20% of women in poll 2 indicating that the media coverage affected their interest in the disease.
This prospective study demonstrated a statistically significant impact of a celebrity announcement on public awareness of breast cancer treatment options. To the best of the authors’ knowledge, theirs is the first study to do so.
The results highlight the importance of media-related impact in improving public awareness of a specific disease.
Breast cancer treatment options received considerable media attention when Angelina Jolie revealed she had undergone double mastectomy.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|